Yesterday, we reported that Sunil Kumar Manna, the head of immunology at India’s Centre for DNA Fingerprinting and Diagnostics, had retracted two papers for image problems.
Turns out Manna will be retracting eight more, he told us today. Here they are: Continue reading Scientist whose work is “not fully supported by the available laboratory records” to retract 8 more papers
A group of Belgian researchers has retracted two decade-old papers in Arthritis & Rheumatism following an investigation and court case.
The papers involved the use of the drug infliximab — sold by Johnson & Johnson as Remicade — to treat Sjögren’s syndrome, an auto-immune condition marked by the destruction of exocrine glands that secrete saliva and tears.
Infliximab is not approved for Sjögren’s. Although the two now-retracted studies suggested that it might be helpful, subsequent data did not support those findings.
Neither, apparently, did the studies themselves. Here’s the retraction notice (it’s a PDF): Continue reading Authors retract two papers on Remicade following legal battles
Noriyuki Takai, a gynecologic cancer researcher at Oita University in Japan who retracted three papers last October, has four more retractions, these in Cancer Letters.
All but one of the notices reads as follows: Continue reading Retraction count for gynecologic cancer researcher Takai grows to seven
Alirio Melendez, who has already retracted five papers and was found by one of his former universities to have committed misconduct on more than 20, has three more retractions.
Here’s the notice for “Antisense Knockdown of Sphingosine Kinase 1 in Human Macrophages Inhibits C5a Receptor-Dependent Signal Transduction, Ca2+ Signals, Enzyme Release, Cytokine Production, and Chemotaxis,” cited 68 times, according to Thomson Scientific’s Web of Knowledge: Continue reading And then there were eight: Three more retractions for Alirio Melendez, all in the Journal of Immunology
The head of immunology at India’s Centre for DNA Fingerprinting and Diagnostics, Sunil Kumar Manna, has retracted two papers for image problems.
Here’s the notice from Cell Death and Differentiation for “Inhibition of RelA phosphorylation sensitizes apoptosis in constitutive NF-kappaB-expressing and chemoresistant cells:” Continue reading Two retractions for scientist whose work is “not fully supported by the available laboratory records”
Let’s say you’re a researcher who’s just gotten reviews back from your latest manuscript, asking for some revisions. Luckily, you find yourself at a conference and spot a presentation that’s related to your work. So you use a bunch of that presentation material in your paper.
Unfortunately for you, the guy who gave that conference presentation sees your paper when it’s published — and he’s justifiably unhappy enough to contact the editors. Continue reading Need more material for your paper under review? Just take it from someone else’s conference presentation
A Saudi engineer has lost his 2012 paper in Renewable and Sustainable Energy Reviews for plagiarizing from two previously published articles, including one in the same journal.
The article, titled “Fresh water production from/by atmospheric air for arid regions, using solar energy: Review,” was written by A.M.K. El-Ghonemy, of Al-Jouf University.
According to the retraction notice:
Continue reading Fresh water paper proves recycled, gets retracted
A group of nutrition researchers at the University of California, Davis has retracted their paper in the International Journal of Molecular Sciences for what they describe as a botched experiment involving mixed-up cultures.
The article, titled “Dextran Sulfate Sodium Inhibits Alanine Synthesis in Caco-2 Cells,” appeared in 2011 and was retracted in February 2012, although it just came to our attention.
According to the abstract:
Continue reading Bowel cell paper falls to culture confusion
Hiroaki Matsubara, a leading Japanese cardiology researcher who has had three papers retracted and another five subject to expressions of concern, has resigned from Kyoto Prefectural University, according to local media.
Mainichi Shimbun reports — according to our roughest of (Google) translations — that Kyoto Prefectural University accepted Matsubara’s resignation following an investigation. That investigation — which the university had told us about last year — revealed serious problems with 27 studies.
As we noted last March: Continue reading After three retractions, five expressions of concern, cardiologist Matsubara resigns post
The Journal of Endocrinology has run a correction for a paper by Rui Curi, the Brazilian scientist whose lawyers threatened Science-Fraud.org after the site ran a number of posts critical of Curi’s work.
Here’s the notice for “Non-esterified fatty acids and human lymphocyte death: a mechanism that involves calcium release and oxidative stress”: Continue reading Another correction for Rui Curi, whose legal threats helped force shutdown of Science Fraud site